Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
If more than 12 hours have passed, skip that dose and take your next dose at the regular time the following day
About SURMOUNT-5 SURMOUNT-5 (NCT05822830) was a 72-week, multi-center, randomized, open-label, Phase 3b trial evaluating the efficacy and safety of Zepbound (tirzepatide) compared with Wegovy (semaglutide) in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea (OSA) or cardiovascular disease, who did not have diabetes
Therefore, ensuring balanced nutrient intake could be crucial for managing both compounds effectively
Fuller Skin 81% say their face didnt hollow out during weight loss
US$ 28.83
US$ 24.77
US$ 24.56
US$ 25.84
US$ 22.62
US$ 26.13
US$ 29.65
US$ 25.98
US$ 20.78
US$ 23.73
